NEW YORK (360Dx) – InBios International said Tuesday that the US Food and Drug Administration has granted 510(k) clearance for its DENV Detect NS1 ELISA, an antigen detection assay that provides a presumptive diagnosis of dengue virus before IgM antibodies are present in a patient.

The test is performed on serum samples taken from patients within the first seven days of their presenting with clinical symptoms that are consistent with either dengue fever or dengue hemorrhagic fever.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.